RAB39B and Parkinson disease: Future studies to explore whether RAB39B deficiency contributes to α-synuclein pathology in vivo, using Lewy body pathological models such as the A53T transgenic mice (Koprich et al., 2017) may help determine the mechanism underlying the pathogenesis of PD caused by RAB39B mutations.